GlassScriptPhysician profile
Allyson F Jacobson
NPI 1619131133
$1,453.39
in general payments reported to CMS, 2019-2025
32 companies · $220 in 2025
The $220 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $351 · 2020: $98.46 · 2021: $40.17 · 2023: $312 · 2024: $432 · 2025: $220.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $964.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $963.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $132.04 | 2019 | |
| Baxter Healthcare | $125.00 | 2019 | |
| Merck Sharp & Dohme LLC | $118.05 | 2019-2025 | Keytruda, Lynparza |
| Csl Behring | $105.77 | 2020-2024 | Kcentra |
| Boston Scientific Corporation | $95.69 | 2024 | Rezum Generator |
| Kerecis Limited | $95.62 | 2023-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Vertex Pharmaceuticals Incorporated | $86.06 | 2024-2025 | |
| Trevena, INC. | $75.35 | 2023-2024 | Olinvyk |
| Hologic Sales and Service, LLC | $67.00 | 2024-2025 | Trunode, Magtrace |
| Dilon Technologies, INC. | $46.67 | 2023 | Hemoblast Bellows |
| Olympus America INC. | $41.82 | 2019-2023 | Itind System, Soltive |
| Teleflex LLC | $40.67 | 2021-2025 | Urolift |
| Cumberland Pharmaceuticals, INC. | $37.43 | 2019-2020 | |
| Convatec INC. | $30.03 | 2023 | |
| Dendreon Pharmaceuticals LLC | $28.21 | 2024 | Provenge |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $28.15 | 2023 | Gattex |
| Tei Biosciences INC | $27.52 | 2019 | |
| Sirius Medical Systems | $24.50 | 2024 | Pintuition |
| Medtronic, INC. | $24.29 | 2025 | Dextile |
| Abbvie INC. | $23.24 | 2024 | |
| Abc Home Medical Supply, INC. | $21.23 | 2024 | |
| Travere Therapeutics, INC. | $20.97 | 2020 | |
| Leica Microsystems INC. | $19.66 | 2019 | |
| Tolmar, INC. | $18.84 | 2025 | Jatenzo, Eligard |
| Myriad Genetic Laboratories, INC. | $17.36 | 2024 | Prolaris |
| Smith+Nephew, INC. | $17.21 | 2024 | Stravix Pl, Oasis |
| Monaghan Medical Corporation | $17.06 | 2023 | Aerobika |
| Lemaitre Vascular, INC. | $15.86 | 2024 | Artegraft Vascular Graft |
| Procept Biorobotics Corporation | $14.14 | 2021 | |
| Neotract INC. | $13.64 | 2020 | |
| Abbott Laboratories | $12.42 | 2021 | |
| Focal Therapeutics, INC. | $11.89 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allyson Jacobson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.